SMTL ID : 3p11.1

anti-EGFR/HER3 Fab DL11 in complex with domains I-III of the HER3 extracellular region

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.70 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG-NAG.1: 6 residues within 4Å: Chain C: H.386, M.387, H.388, N.389, S.421, Q.497 No protein-ligand interaction detected (PLIP)

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain C: N.334, T.370 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:T.370 NAG.3: 3 residues within 4Å: Chain C: P.385, N.418, Q.442 3 PLIP interactions: 3 interactions with chain C Hydrophobic interactions: C:P.385 Hydrogen bonds: C:N.418, C:Q.442

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schaefer, G. et al., A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies. Cancer Cell (2011)

Release Date

2011-10-26

Peptides

Fab DL11 heavy chain: A
Fab DL11 light chain: B
Receptor tyrosine-protein kinase erbB-3: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
A

Fab DL11 heavy chain

Fab DL11 light chain

Receptor tyrosine-protein kinase erbB-3

Related Entries With Identical Sequence